Skip to content

Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome

Timing of Umbilical Cord Clamping During an Elective Caesarean Delivery and Its Association With Neonatal Gut Microbiome.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06030713
Acronym
CSBabyBiome
Enrollment
33
Registered
2023-09-11
Start date
2019-03-01
Completion date
2023-03-01
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Side Effect, Cesarean Section Complications, Microbial Colonization

Brief summary

In this study, investigators seek to determine whether the timing of antibiotics given to mothers during an elective C-section affects the composition of their infant's gut microbiome. To do this, a randomized controlled trial (RCT) was carried out with women undergoing elective C-sections. These women were either given antibiotics before the skin incision (AB+) or after the umbilical cord was clamped (AB-).

Detailed description

Rationale: During a caesarean delivery, umbilical cord clamping can occur before or after administering a perioperative prophylactic antibiotic to the mother. If the cord is clamped before the antibiotic administration, this antibiotic cannot reach the infant. Conversely, if the cord is clamped after the antibiotic administration, these maternal antibiotics cross the placenta and enter the infant's circulation. In this study, investigators hypothesize that such antibiotics modify the composition and functionality of the neonatal gut microbiome. A changed neonatal microbiome associates with the onset of asthma, allergies, type 1 diabetes, and obesity later in life. Such a small intervention could influence the future health of the infant significantly. Objective: The primary aim of this study is to contrast the composition and functionality of the neonatal gut microbiome from mothers given antibiotic prophylaxis before skin incision with the microbiome of neonates from mothers given the antibiotic after umbilical cord clamping during an elective caesarean delivery. Study design: Randomized controlled trial Study population: Pregnant women at \>38 weeks of gestation undergoing elective caesarean section at the UMCG will be randomized into two groups. The gut microbiome of the neonates from both groups will be analyzed. Intervention: The timing of umbilical cord clamping differs between the two groups. One gram of Cefazolin (once, intravenous) will be administered to one group before skin incision, while 1g cefazolin will be given to another group after umbilical cord clamping during an elective caesarean section. Main study parameters/endpoints: The primary endpoint of this study is the variance in the composition and functionality of the neonatal gut microbiome over a year, contrasting neonates from mothers given antibiotic prophylaxis before skin incision with neonates from mothers given the antibiotic after umbilical cord clamping.

Interventions

DRUGCefazolin

Cord clamping before or after antibiotic (cefazolin) prophylaxis

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Intervention model description

Timing of umbilical cord clamping is different in the two arms. One gram of Cefazolin (once, intravenous) will be given to one group of women before skin incision compared to 1g cefazolin given to another group of women after umbilical cord clamping during an elective caesarean section.

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Years
Healthy volunteers
Yes

Inclusion criteria

* Females undergoing elective CS at the UMCG * Gestational age in weeks equal to or above 38 weeks

Exclusion criteria

* Cephalosporin allergy * Exposure to antibiotic agent 2 weeks before CS * Temperature \>37.5 C before CS * Pre-labour rupture of membranes * Emergency CS * No -20 freezer at home * No command of the Dutch language

Design outcomes

Primary

MeasureTime frameDescription
Infant microbial species level differences between two groupsFirst 6 weeks of lifeCentered log ratio transformed relative abundance differences of bacterial species (relative abundance of \> 0.05% and present in at least 2 infants) between two interventional groups
Infant Alpha Diversity differences between two groupsFirst 6 weeks of lifeAlpha Diversity difference measured by the Shannon Diversity Index of infant microbiome at species level between two interventional groups
Infant Beta Diversity differences between two groupsFirst 6 weeks of lifeBeta Diversity difference in Aitchison distances between the two intervention groups
Infant Antibiotic Resistance total gene load differences between two groupsFirst 6 weeks of lifeInfant Antibiotic Resistance total gene load differenced measured in RPKM between the two interventional groups

Secondary

MeasureTime frameDescription
Number of participants with post c-section maternal wound infectionFirst 6 weeks of lifeNumber of participants with early and late post C-section wound infection in mothers

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026